ProShares Trust > ProShares Trust
ProShares Ultra Health Care
Exchange-Traded Fund
Inverse of a benchmark
Index Fund
Series ID: S000014253
LEI: XMUK3X5V9HUTXR1NFE09
SEC CIK: 1174610
$84.04M
Avg Monthly Net Assets
$87.07M
Total Assets
$127K
Total Liabilities
$86.95M
Net Assets
ProShares Ultra Health Care is an Exchange-Traded Fund in ProShares Trust
from ProShares Trust,
based in Maryland,
United States of America.
The fund has one share class
and monthly net assets of $84.04M.
On July 29th, 2024 it reported 77 holdings, the largest
being United States of America (11.4%), Eli Lilly & Co. (9.3%) and UnitedHealth Group, Inc. (6.5%).
Data provided by Fincoded.
Share Classes
| Name | Class/Contract ID | Exchange | Ticker | Monthly Returns (2 years) |
|---|---|---|---|---|
| ProShares Ultra Health Care | C000038812 | ARCX | RXL |
Holdings
From latest NPORT-P, filed July 29th, 2024 for period ending May 31st, 2024.
Historic holdings data available from Fincoded.
| Name | Profile | Category | Country | Value $USD | # Shares | % of Fund |
|---|---|---|---|---|---|---|
| Abbott Laboratories | Long | Equity-common | US | $2M | 21K | 2.51 |
| AbbVie, Inc. | Long | Equity-common | US | $4M | 22K | 4.03 |
| Agilent Technologies, Inc. | Long | Equity-common | US | $471K | 4K | 0.54 |
| Align Technology, Inc. | Long | Equity-common | US | $226K | 878 | 0.26 |
| Amgen, Inc. | Long | Equity-common | US | $2M | 7K | 2.32 |
| Baxter International, Inc. | Long | Equity-common | US | $213K | 6K | 0.25 |
| Becton Dickinson & Co. | Long | Equity-common | US | $826K | 4K | 0.95 |
| Bio-Rad Laboratories, Inc., Class A | Long | Equity-common | US | $74K | 258 | 0.09 |
| Bio-Techne Corp. | Long | Equity-common | US | $150K | 2K | 0.17 |
| Biogen, Inc. | Long | Equity-common | US | $402K | 2K | 0.46 |
| Boston Scientific Corp. | Long | Equity-common | US | $1M | 18K | 1.57 |
| Bristol-Myers Squibb Co. | Long | Equity-common | US | $1M | 25K | 1.19 |
| Cardinal Health, Inc. | Long | Equity-common | US | $298K | 3K | 0.34 |
| Catalent, Inc. | Long | Equity-common | US | $120K | 2K | 0.14 |
| Cencora, Inc. | Long | Equity-common | US | $462K | 2K | 0.53 |
| Centene Corp. | Long | Equity-common | US | $472K | 7K | 0.54 |
| Charles River Laboratories International, Inc. | Long | Equity-common | US | $132K | 632 | 0.15 |
| Cigna Group (The) | Long | Equity-common | US | $1M | 4K | 1.43 |
| Cooper Cos., Inc. (The) | Long | Equity-common | US | $231K | 2K | 0.27 |
| CVS Health Corp. | Long | Equity-common | US | $924K | 16K | 1.06 |
| Danaher Corp. | Long | Equity-common | US | $2M | 8K | 2.39 |
| DaVita, Inc. | Long | Equity-common | US | $98K | 664 | 0.11 |
| Dexcom, Inc. | Long | Equity-common | US | $564K | 5K | 0.65 |
| Edwards Lifesciences Corp. | Long | Equity-common | US | $649K | 7K | 0.75 |
| Elevance Health, Inc. | Long | Equity-common | US | $2M | 3K | 1.79 |
| Eli Lilly & Co. | Long | Equity-common | US | $8M | 10K | 9.27 |
| GE HealthCare Technologies, Inc. | Long | Equity-common | US | $407K | 5K | 0.47 |
| Gilead Sciences, Inc. | Long | Equity-common | US | $987K | 15K | 1.14 |
| HCA Healthcare, Inc. | Long | Equity-common | US | $829K | 2K | 0.95 |
| Henry Schein, Inc. | Long | Equity-common | US | $111K | 2K | 0.13 |
| Hologic, Inc. | Long | Equity-common | US | $213K | 3K | 0.25 |
| Humana, Inc. | Long | Equity-common | US | $539K | 2K | 0.62 |
| IDEXX Laboratories, Inc. | Long | Equity-common | US | $508K | 1K | 0.58 |
| Illumina, Inc. | Long | Equity-common | US | $204K | 2K | 0.23 |
| Incyte Corp. | Long | Equity-common | US | $132K | 2K | 0.15 |
| Insulet Corp. | Long | Equity-common | US | $153K | 861 | 0.18 |
| Intuitive Surgical, Inc. | Long | Equity-common | US | $2M | 4K | 2.01 |
| IQVIA Holdings, Inc. | Long | Equity-common | US | $493K | 2K | 0.57 |
| Johnson & Johnson | Long | Equity-common | US | $4M | 30K | 5.00 |
| Labcorp Holdings, Inc. | Long | Equity-common | US | $204K | 1K | 0.23 |
| McKesson Corp. | Long | Equity-common | US | $922K | 2K | 1.06 |
| Medtronic plc | Long | Equity-common | IE | $1M | 16K | 1.53 |
| Merck & Co., Inc. | Long | Equity-common | US | $4M | 31K | 4.51 |
| Mettler-Toledo International, Inc. | Long | Equity-common | US | $372K | 265 | 0.43 |
| Moderna, Inc. | Long | Equity-common | US | $583K | 4K | 0.67 |
| Molina Healthcare, Inc. | Long | Equity-common | US | $225K | 715 | 0.26 |
| Pfizer, Inc. | Long | Equity-common | US | $2M | 70K | 2.29 |
| Quest Diagnostics, Inc. | Long | Equity-common | US | $194K | 1K | 0.22 |
| Regeneron Pharmaceuticals, Inc. | Long | Equity-common | US | $1M | 1K | 1.47 |
| Repurchase Agreement | Long | Repurchase agreement | US | $2M | – | 1.84 |
| Repurchase Agreement | Long | Repurchase agreement | US | $516K | – | 0.59 |
| Repurchase Agreement | Long | Repurchase agreement | US | $377K | – | 0.43 |
| Repurchase Agreement | Long | Repurchase agreement | US | $272K | – | 0.31 |
| Repurchase Agreement | Long | Repurchase agreement | US | $52K | – | 0.06 |
| ResMed, Inc. | Long | Equity-common | US | $374K | 2K | 0.43 |
| Revvity, Inc. | Long | Equity-common | US | $166K | 2K | 0.19 |
| Solventum Corp. | Long | Equity-common | US | $101K | 2K | 0.12 |
| STERIS plc | Long | Equity-common | IE | $271K | 1K | 0.31 |
| Stryker Corp. | Long | Equity-common | US | $1M | 4K | 1.63 |
| Teleflex, Inc. | Long | Equity-common | US | $121K | 579 | 0.14 |
| Thermo Fisher Scientific, Inc. | Long | Equity-common | US | $3M | 5K | 3.11 |
| Total Return Swap | Derivative-equity | US | $4M | – | 4.34 | |
| Total Return Swap | Derivative-equity | US | $2M | – | 1.74 | |
| Total Return Swap | Derivative-equity | US | $1M | – | 1.61 | |
| Total Return Swap | Derivative-equity | US | $805K | – | 0.93 | |
| Total Return Swap | Derivative-equity | US | $295K | – | 0.34 | |
| Total Return Swap | Derivative-equity | US | $60K | – | 0.07 | |
| U.S. Treasury Bills (United States of America) | Long | Short-term investment vehicle | US | $10M | – | 11.39 |
| U.S. Treasury Bills (United States of America) | Long | Short-term investment vehicle | US | $993K | – | 1.14 |
| UnitedHealth Group, Inc. | Long | Equity-common | US | $6M | 11K | 6.49 |
| Universal Health Services, Inc., Class B | Long | Equity-common | US | $143K | 751 | 0.16 |
| Vertex Pharmaceuticals, Inc. | Long | Equity-common | US | $1M | 3K | 1.66 |
| Viatris, Inc. | Long | Equity-common | US | $157K | 15K | 0.18 |
| Waters Corp. | Long | Equity-common | US | $225K | 729 | 0.26 |
| West Pharmaceutical Services, Inc. | Long | Equity-common | US | $302K | 912 | 0.35 |
| Zimmer Biomet Holdings, Inc. | Long | Equity-common | US | $297K | 3K | 0.34 |
| Zoetis, Inc., Class A | Long | Equity-common | US | $959K | 6K | 1.10 |
Address
ProShares Trust
7272 Wisconsin Avenue
Bethesda
Maryland
20814
United States of America
Websites
Directors
Russell S. Reynolds, III
Michael L. Sapir
Michael C. Wachs
William D. Fertig
Transfer Agents
JPMORGAN CHASE BANK, N.A.
Pricing Services
LSEG
ICE Data Pricing & Reference Data, LLC
Bloomberg L.P.
Custodians
JPMorgan Chase Bank, N.A.
Shareholder Servicing Agents
N/A
Admins
Citi Fund Services Ohio, Inc.
JPMORGAN CHASE BANK, N.A.
Brokers
Societe Generale